VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MRXMarex Group plc Ordinary Shares
$64.23$4.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMRXBalance Sheet

Marex Group plc Ordinary Shares (MRX) Balance Sheet

13Y historyFree accessUpdated daily

The firm's aggressive asset expansion to $34.7B has been supported by a significant increase in leverage, resulting in a debt-to-equity ratio of 8.05 as of 2025Q4.

MRX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets24.53B23.83B16.94B15.35B4.12B291.55M217.5M00000310.02M
Cash & Short-Term Investments-------------
Cash Only-------------
Short-Term Investments-------------
Accounts Receivable-------------
Days Sales Outstanding-------------
Inventory-------------
Days Inventory Outstanding-------------
Other Current Assets08.52B4.05B2.69B1.11B00000000
Total Non-Current Assets10.15B484M675.6M389.7M1.14B3.48B2.36B1.39B1.08B1.14B1.11B953.14M916.43M
Property, Plant & Equipment110.9M80.7M57.2M45.5M20.9M20.39M27.71M2.48M2.67M2.5M3.78M7.05M11.04M
Fixed Asset Turnover32.73x35.87x41.12x25.83x40.75x37.14x19.82x154.96x118.93x131.27x91.53x52.22x32.44x
Goodwill0176.5M163.6M155.5M208.9M198.4M179.18M140.97M140.97M140.97M140.97M143.97M145.6M
Intangible Assets335.4M56.5M56M25.6M21.5M14.35M7.83M1.86M776K537K771K911K1.62M
Long-Term Investments5.89B77.5M77M22M84.8M00000000
Other Non-Current Assets-------------
Total Assets34.68B24.31B17.61B15.74B5.26B3.77B2.58B1.39B1.08B1.14B1.11B953.14M1.23B
Asset Turnover0.10x0.12x0.13x0.07x0.16x0.20x0.21x0.28x0.29x0.29x0.31x0.39x0.29x
Asset Growth %42.62%38.05%11.86%199.05%39.76%46%84.96%28.6%-4.46%2.49%16.22%-22.28%-
Total Current Liabilities7.75B21.78B15.88B14.56B4.63B122.37M84.16M0000067.86M
Accounts Payable07.74B4.92B6.65B3.29B00000000
Days Payables Outstanding-------------
Short-Term Debt7.75B4.58B4.43B5.22B1.13B00000000
Deferred Revenue (Current)-------------
Other Current Liabilities07.41B4.65B2.42B200.3M084.16M-70.79M-57.19M-58.85M-65.79M-66.19M67.86M
Current Ratio3.16x1.09x1.07x1.05x0.89x2.38x2.58x-----4.57x
Quick Ratio3.16x1.09x1.07x1.05x0.89x2.38x2.58x-----4.57x
Cash Conversion Cycle-------------
Total Non-Current Liabilities25.66B1.56B951M504.3M156.8M3.2B2.08B1.01B712.27M761.5M734.13M595.85M0
Long-Term Debt2.33B1.48B907.9M472.1M136.6M246.76M12.95M000000
Capital Lease Obligations-------------
Deferred Tax Liabilities-------------
Other Non-Current Liabilities-------------
Total Liabilities33.41B23.34B16.84B15.07B4.79B3.32B2.16B1.01B712.27M761.5M734.13M595.85M67.86M
Total Debt10.17B6.14B5.39B5.73B1.29B246.76M12.95M000000
Net Debt3.79B3.58B3.9B4.82B578.1M-44.79M-204.56M-160.73M-89.22M-188.18M-158.26M-159.1M-310.02M
Debt / Equity8.05x6.28x6.94x8.45x2.70x0.56x0.03x------
Debt / EBITDA8.50x7.10x7.64x20.15x16.35x12.24x-------
Net Debt / EBITDA3.17x4.14x5.53x16.95x7.33x-2.22x--3.55x-3.53x-7.15x-6.96x-10.54x-
Interest Coverage1.54x1.55x1.45x1.64x3.65x--------
Total Equity1.26B976.9M775.9M677.7M477.7M443.79M417.75M381.93M372.38M373.83M373.59M357.29M338.8M
Equity Growth %29.35%25.91%14.49%41.87%7.64%6.23%9.38%2.56%-0.39%0.07%4.56%5.46%-
Book Value per Share16.6012.9810.749.576.757.326.896.306.146.176.165.895.59
Total Shareholders' Equity1.26B976.9M775.9M677.7M477.7M443.79M417.75M381.93M372.38M373.83M373.59M357.29M338.8M
Common Stock100K100K100K100K100K23K23K21K176.24M21K21K20.59K20.59K
Retained Earnings982M722.4M555.3M455.3M346.6M132.64M107.01M72.28M62.13M64.63M64.14M46.49M28.62M
Treasury Stock-58.5M-23.2M-9.8M-7.9M000000000
Accumulated OCI15.4M-22.6M-1.6M-1.7M-3.3M176.8M176.39M175.12M-295K174.88M175.14M176.5M175.87M
Minority Interest-200K000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

High leverage and liquidity

Rapid Asset Expansion Through Leverage

As reported in financial statements, Marex's total assets surged from $3.8B in 2020Q4 to $34.7B by 2025Q4, a trajectory that suggests aggressive inorganic growth and increased balance sheet scale, though this expansion has been accompanied by a significant rise in total liabilities over the same period.

The rapid growth in the balance sheet appears to be driven by the firm's strategic acquisition path and the scaling of its clearing operations. Investors should monitor whether this asset growth is generating commensurate returns or if it primarily reflects the accumulation of client-segregated assets that carry minimal margin.

Elevated Leverage Amidst M&A Activity

Based on the provided balance sheet data, Marex's debt-to-equity ratio reached 8.05 in 2025Q4, a substantial increase from 0.56 in 2020Q4, which indicates that the firm is increasingly reliant on debt financing to support its capital-intensive clearing and market-making activities.

The high leverage ratio suggests that the firm's capital structure is sensitive to interest rate environments and credit market conditions. This reliance on debt may limit financial flexibility, particularly if regulatory capital requirements tighten or if market volatility necessitates higher liquidity buffers.

Liquidity Buffers Masked by Segregation

According to recent SEC filings, Marex reported $13.5B in cash as of 2025Q4, yet the current ratio of 3.16 warrants cautious interpretation, as a significant portion of these liquid assets likely represents client-segregated funds rather than unrestricted corporate cash available for operational or strategic deployment.

The fluctuation in the current ratio, which spiked from 1.09 in 2024Q4 to 3.16 in 2025Q4, suggests that liquidity metrics are heavily influenced by the timing of client margin inflows and outflows. Analysts should distinguish between these restricted balances and the firm's true free cash position.

Equity Base Diluted by Growth

As indicated by the reported figures, Marex's equity base has grown to $1.3B in 2025Q4 from $443.8M in 2020Q4, yet the persistent reliance on debt suggests that retained earnings growth has not been sufficient to fully fund the firm's aggressive expansion and acquisition strategy.

The modest growth in retained earnings relative to the expansion of total assets may imply that the firm is prioritizing scale over capital self-sufficiency. Investors should monitor whether future equity growth can keep pace with the firm's leverage requirements to avoid further dilution or balance sheet strain.

Hidden Risks in Asset Composition

Based on the provided data, the firm's net PPE remains minimal at $110.9M despite a $34.7B asset base, which suggests that the balance sheet is dominated by financial instruments and client-related receivables rather than tangible productive assets, creating potential exposure to counterparty and market-to-market risks.

The lack of significant physical assets highlights that the firm's value is tied to its clearing status and financial intermediation, which are inherently sensitive to market dislocations. This structure makes the balance sheet appear more robust than it may be during periods of extreme commodity market stress.

MRX — Frequently Asked Questions

Quick answers to the most common questions about buying MRX stock.

What are the total assets of Marex Group plc Ordinary Shares (MRX)?

As of 2025, Marex Group plc Ordinary Shares (MRX) had total assets of $34.68B including $24.53B in current assets.

How much debt does Marex Group plc Ordinary Shares (MRX) have?

Marex Group plc Ordinary Shares (MRX) carries total debt of $10.17B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Marex Group plc Ordinary Shares?

Marex Group plc Ordinary Shares (MRX) has total shareholders' equity (book value) of $1.26B ($16.60 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Marex Group plc Ordinary Shares's current ratio and liquidity?

Marex Group plc Ordinary Shares (MRX) reported a current ratio of 3.16x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.